Molecular epidemiology and antimicrobial resistance patterns of carbapenem-resistant Acinetobacter baumannii isolates from patients admitted at ICUs of a teaching hospital in Zunyi, China

Front Cell Infect Microbiol. 2023 Dec 1:13:1280372. doi: 10.3389/fcimb.2023.1280372. eCollection 2023.

Abstract

Background: Carbapenem-resistant Acinetobacter baumannii (CRAB) has emerged as a predominant strain of healthcare-associated infections worldwide, particularly in intensive care units (ICUs). Therefore, it is imperative to study the molecular epidemiology of CRAB in the ICUs using multiple molecular typing methods to lay the foundation for the development of infection prevention and control strategies. This study aimed to determine the antimicrobial susceptibility profile, the molecular epidemiology and conduct homology analysis on CRAB strains isolated from ICUs.

Methods: The sensitivity to various antimicrobials was determined using the minimum inhibitory concentration (MIC) method, Kirby-Bauer disk diffusion (KBDD), and E-test assays. Resistance genes were identified by polymerase chain reaction (PCR). Molecular typing was performed using multilocus sequence typing (MLST) and multiple-locus variable-number tandem repeat analysis (MLVA).

Results: Among the 79 isolates collected, they exhibited high resistance to various antimicrobials but showed low resistance to levofloxacin, trimethoprim-sulfamethoxazole, and tetracyclines. Notably, all isolates of A. baumannii were identified as multidrug-resistant A. baumannii (MDR-AB). The bla OXA-51-like, adeJ, and adeG genes were all detected, while the detection rates of bla OXA-23-like (97.5%), adeB (93.67%), bla ADC (93.67%), qacEΔ1-sul1 (84.81%) were higher; most of the Ambler class A and class B genes were not detected. MLST analysis on the 79 isolates identified five sequence types (STs), which belonged to group 3 clonal complexes 369. ST1145Ox was the most frequently observed ST with a count of 56 out of 79 isolates (70.89%). MLST analysis for non-sensitive tigecycline isolates, which were revealed ST1145Ox and ST1417Ox as well. By using the MLVA assay, the 79 isolates could be grouped into a total of 64 distinct MTs with eleven clusters identified in them. Minimum spanning tree analysis defined seven different MLVA complexes (MCs) labeled MC1 to MC6 along with twenty singletons. The locus MLVA-AB_2396 demonstrated the highest Simpson's diversity index value at 0.829 among all loci tested in this study while also having one of the highest variety of tandem repeat species.

Conclusion: The molecular diversity and clonal affinities within the genomes of the CRAB strains were clearly evident, with the identification of ST1144Ox, ST1658Ox, and ST1646Oxqaq representing novel findings.

Keywords: Carbapenem-resistant Acinetobacter baumannii (CRAB); antibiotic resistance; intensive care units (ICUs); molecular epidemiology; multilocus sequence typing(MLST); multiple-locus variable-number tandem repeat analysis(MLVA).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acinetobacter baumannii* / genetics
  • Anti-Bacterial Agents* / pharmacology
  • Anti-Bacterial Agents* / therapeutic use
  • Carbapenems / pharmacology
  • China / epidemiology
  • Drug Resistance, Bacterial / genetics
  • Hospitals, Teaching
  • Humans
  • Intensive Care Units
  • Microbial Sensitivity Tests
  • Molecular Epidemiology
  • Multilocus Sequence Typing / methods
  • beta-Lactamases / genetics

Substances

  • Anti-Bacterial Agents
  • beta-Lactamases
  • Carbapenems

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The project received support from the Guizhou High-level (BAI) Innovative Talents Project (QIANKehe Platform & Talents-GCC[2022]042-1), the National Natural Science Foundation of China (No.81760475), the Innovation Group Project provided by Guizhou Provincial Department of Education (QianJiaoheKYzi [2021]019), the Key Discipline Project of Clinical Laboratory Diagnostics funded by Guizhou Provincial Health Commission (QianWeijianhan[2021]160), the Key Discipline Project of Clinical Laboratory Diagnostics funded by Zunyi Municipal Health Bureau (2022-1444), the Zunyi United Science and Technology Fund Project (Zunyi Kehe HZzi [2018]159), the Science and Technology Fund Project of Guizhou Provincial Health Commission (gzwkj2021-367), and Guizhou Provincial Basic Research Program(Natural Science) (No.ZK[2023]488).